tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
Advertisement

Tvardi Therapeutics (TVRD) Stock Investors

Compare
2,535 Followers
Based on 830,143 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TVRD
On average, investors allocate 2.31% of their portfolios to TVRD
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 830,143 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TVRD

1.0%
Last 7
Days
6.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TVRD, out of 830,143 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TVRD Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
5.00%
$29.75
Opened
0.00%
$26.52
Opened
0.56%
$28.05
Increased
0.00%
$31.82
Increased
6.33%
$5.65
Increased
<0.01%
$5.16
Based on the activity of investors who made their portfolios public
The table shows changes in TVRD in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TVRD Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
4.31%
+3.51%
+5.34%
6.00B
Financial
Bristol-Myers Squibb
2.91%
+1.12%
+3.58%
100.16B
Healthcare
CVS Health
3.45%
+0.78%
+0.07%
102.01B
Healthcare
Delta Air Lines
4.00%
-0.31%
-1.06%
41.85B
Industrials
Ford Motor
4.47%
-0.66%
-1.51%
52.92B
Consumer Cyclical
JD
3.23%
-1.10%
-0.74%
47.88B
Consumer Cyclical
Viking Therapeutics
3.72%
-0.38%
+0.59%
4.16B
Healthcare
Block
2.78%
-0.95%
-1.90%
40.59B
Technology
Crispr Therapeutics AG
3.11%
+0.63%
+1.04%
5.10B
Healthcare
Nio
4.82%
-0.48%
-0.03%
11.70B
Consumer Cyclical
Based on the activity of 830,143 active portfolios
Open your Smart Portfolio

TVRD Investor Analysis

TVRD investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.3%
of TVRD holders
are under 35
Average Segment Performance
Average P/E Ratio37.77
Beta-3.56
Dividend Yield5.01%
TVRD investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.8%
of TVRD holders
are between 35–55
Average Segment Performance
Average P/E Ratio34.48
Beta5.28
Dividend Yield5.07%
TVRD investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
51.9%
of TVRD holders
are over 55
Average Segment Performance
Average P/E Ratio32.80
Beta0.79
Dividend Yield3.92%
Overview of age group and performance of TVRD stock investors
See who invests in TVRD according to age group and performance.

FAQ

How many retail Investors hold TVRD?
<0.1% of TipRanks' retail investors hold TVRD in their portfolios.
    What is TVRD Investor Sentiment?
    TVRD’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of TVRD in the last 7 days?
      ▼ 1.0% of TipRanks' retail investors changed their holding of TVRD in the last 7 days.
        What percentage of retail investors changed their holding of TVRD in the last 30 days?
        ▼ 6.2% of TipRanks' retail investors changed their holding of TVRD in the last 30 days.
          What is the average age of retail investors who hold TVRD?
          The average age of TVRD Holders is over 55.
            What other stocks have TVRD investors also bought?
            TVRD Investors also bought RIOT, BMY, CVS, DAL, F, JD, VKTX, XYZ, CRSP, NIO.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis